Fresenius partners with more than 1,000 nephrology providers for new kidney care payment model
Fresenius Medical Care North America has announced partnerships with more than 1,000 nephrology providers as part of the Kidney Care Choices (KCC) model. Through the KCC, which the Centers for Medicare and Medicaid Services (CMS) announced in 2019 and formally began in 2022, Fresenius will help manage care for more than 50,000 individuals by providing specialized education, increasing preemptive transplants and increasing the prevalence of planned start to life-sustaining treatment. The partnerships include 20 of the 55 approved Kidney Contracting Entities announced by CMS.
Labor|New ActivityIn response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.
Lorem Ipsum text header Report Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.